Skip to main content

ETF comparison

FHLC vs VHT

Both Healthcare.

Fidelity MSCI Health Care Index ETF · Vanguard Health Care Index Fund ETF Shares

Holdings overlap

Weighted by ISIN/CUSIP
96.5 %

321 positions appear in both funds. Buying equal dollars of FHLC and VHT would leave roughly 96.5% of each dollar exposed to the same underlying securities.

FHLC unmatched 3.3% Shared 96.5% VHT unmatched 3.3%

Unmatched is the part of a fund's weight the other fund doesn't match: names only it holds, plus any extra weight it puts in names both funds hold.

In FHLC only
13 positions
Shared
321 positions
In VHT only
92 positions

Side by side

FHLC

Fidelity MSCI Health Care Index ETF

Fidelity · Healthcare

80 composite / 100
Expense ratio
0.084%
Net assets
$3.95B
TTM yield
1.13%
Top-10 conc.
51.9%
VHT

Vanguard Health Care Index Fund ETF Shares

Vanguard · Healthcare

84 composite / 100
Expense ratio
0.090%
Net assets
$23.73B
whole fund, 2 share classes
TTM yield
1.32%
Top-10 conc.
51.7%

Sub-score comparison

92
Cost
91
83
Tax efficiency
83
82
Liquidity
100
40
Concentration
40
—
Tracking quality
—
FHLC sub-score VHT

Tracking quality isn't part of the composite — see what we don't score for why.

Cost difference

FHLC is 1 bps cheaper than VHT. On a $100,000 position that's about $6/yr more in fees for VHT.

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open the cost calculator pre-filled with FHLC vs VHT.

Top shared holdings

321 shared in total
# Holding In FHLC In VHT Overlap
1 Eli Lilly & Co 13.35% 12.87% 12.87%
2 Johnson & Johnson 8.93% 8.75% 8.75%
3 AbbVie Inc 6.42% 6.28% 6.28%
4 UnitedHealth Group Inc 5.44% 4.90% 4.90%
5 Merck & Co Inc 4.66% 5.06% 4.66%
6 Thermo Fisher Scientific Inc 3.09% 3.18% 3.09%
7 Amgen Inc 3.00% 3.21% 3.00%
8 Abbott Laboratories 2.66% 2.66% 2.66%
9 Gilead Sciences Inc 2.34% 2.52% 2.34%
10 Pfizer Inc 2.06% 2.24% 2.06%
11 Bristol-Myers Squibb Co 1.93% 1.89% 1.89%
12 Intuitive Surgical Inc 1.82% 1.85% 1.82%

Only in FHLC

13 total
  • Royalty Pharma PLC 0.35%
  • Xenon Pharmaceuticals Inc 0.07%
  • CRISPR Therapeutics AG 0.06%
  • VeraDermics Inc 0.02%
  • Damora Therapeutics Inc 0.02%
  • Nutex Health Inc 0.01%
  • WaVe Life Sciences Ltd 0.01%
  • LB Pharmaceuticals Inc 0.01%
  • CONTRA AKOUOS INC 0.00%
  • CONTRA HOLOGIC INCORPO 0.00%

Only in VHT

92 total
  • Summit Therapeutics Inc 0.02%
  • agilon health Inc 0.01%
  • Rigel Pharmaceuticals Inc 0.01%
  • Maravai LifeSciences Holdings Inc 0.01%
  • Varex Imaging Corp 0.01%
  • Replimune Group Inc 0.01%
  • CryoPort Inc 0.01%
  • Mesa Laboratories Inc 0.01%
  • Aura Biosciences Inc 0.01%
  • Aclaris Therapeutics Inc 0.01%

Percentages are holdings overlap with the named fund.

Open FHLC or VHT at a brokerage

Both funds trade commission-free at major US brokerages.

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.